Does Requip (ropinirole) affect blood pressure?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 17, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Does Requip (Ropinirole) Affect Blood Pressure?

Yes, Requip (ropinirole) significantly affects blood pressure, primarily causing orthostatic hypotension (low blood pressure upon standing) and general hypotension, particularly when initiating therapy or increasing doses. 1

Key Blood Pressure Effects

Hypotension and Orthostatic Hypotension

Ropinirole can decrease blood pressure, especially when you start taking it or when your dose is changed 1. The orthostatic hypotension manifests as:

  • Fainting or feeling dizzy
  • Nausea or sweating when standing up from sitting or lying down
  • Decreased heart rate may accompany these episodes 1

Patients should change position from lying down or sitting to standing carefully and slowly to minimize symptomatic drops in blood pressure 1.

Paradoxical Blood Pressure Increase

Importantly, the FDA label also warns that ropinirole may increase blood pressure in some patients 1. This bidirectional effect means blood pressure monitoring is essential regardless of baseline status.

Clinical Evidence

Research confirms these effects across multiple studies:

  • A 2021 case report documented severe orthostatic hypotension in a 71-year-old man on ropinirole 0.25 mg three times daily for restless leg syndrome, resulting in four falls over eight months and requiring midodrine treatment. Discontinuing ropinirole completely resolved the orthostatic symptoms 2.

  • A 2013 Chinese trial found orthostatic hypotension occurred in >5% of patients, making it one of the most common adverse events 3.

  • A 2008 prospective study reported orthostatic hypotension, though less frequently than nausea and sleepiness 4.

  • A 1998 study showed ropinirole caused a small but measurable reduction in noradrenaline release during orthostatic challenge, though this was less pronounced than with ergot dopamine agonists 5.

Critical Clinical Considerations

High-Risk Scenarios

The blood pressure effects are most pronounced during:

  • Treatment initiation
  • Dose escalation
  • In elderly patients (who are particularly susceptible) 2
  • When combined with other medications causing drowsiness or hypotension 1

Monitoring Requirements

Check blood pressure both supine and standing before starting ropinirole and after dose changes. Patients with baseline orthostatic hypotension should be excluded or monitored extremely closely 5.

Drug Interactions

The hypotensive effects can be mitigated by domperidone pretreatment (20 mg given 1 hour before ropinirole), which prevented postural symptoms in nearly all subjects in one study 6. However, this is not standard practice and requires careful consideration.

Practical Management Algorithm

  1. Before prescribing: Measure supine and standing blood pressure; exclude patients with >10 mmHg orthostatic drop 5
  2. During titration: Instruct patients to rise slowly from seated/supine positions 1
  3. If symptomatic hypotension occurs:
    • Consider dose reduction
    • Review concomitant medications (especially antihypertensives, diuretics)
    • If severe, discontinue ropinirole 2
  4. Monitor for paradoxical hypertension: Some patients may experience blood pressure increases requiring different management 1

Common Pitfall

Do not assume ropinirole only lowers blood pressure—the bidirectional effect means both hypotension and hypertension require monitoring. Additionally, prescribing cascade can occur when orthostatic hypotension from ropinirole leads to unnecessary additional medications like midodrine 2.

References

Related Questions

Can ropinirole cause hypertension in patients, particularly those with a history of hypertension?
What are the indications, recommended dosing schedules, contraindications, and common adverse effects of ropinirole?
What are the expected vital signs in a patient who has overdosed on ropinirole (Requip)?
Can ropinirole (a dopamine agonist) cause bradycardia?
How is orthostatic hypotension managed in patients taking Ropinirole (a dopamine agonist)?
In a patient concerned about foot drop due to an altered gait with a sensation of lifting the foot, who has experienced twitching for 12 months, can still jump, run, and walk on heels, and has hip pain, what is the appropriate evaluation and management?
What diseases does Naegleria fowleri cause, how does it evade host defenses, which organs are involved, what are the clinical manifestations and disease course, is recovery possible, are there long‑term sequelae, and is there any latency period?
What is the appropriate treatment for middle‑ear fluid (otitis media with effusion)?
Is an 820 mg dose of magnesium sulfate appropriate for a 4‑year‑old child weighing 16.4 kg?
Which pediatric viruses cause concomitant bilateral viral conjunctivitis on the first day of fever?
In a patient who develops rhinorrhea followed within hours by sore throat and hoarseness, is the cause more likely viral pharyngitis rather than bacterial streptococcal pharyngitis?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.